Bibliographic information
GuidelineWHO guidelines on hepatitis B and C testing.
Year of Publication2017
Issuing InstitutionWHO
Recommendation
Maintained
Monitoring for HBV treatment response and disease progression. In persons who do not yet meet the criteria for antiviral therapy: i.e. persons who have intermittently abnormal ALT levels or HBV DNA levels that fluctuate between 2000 IU/mL and 20 000 IU/mL (where HBV DNA testing is available) and in HIV coinfected persons
Recommended in favor
Conditional
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year2015
InstitutionWorld Health Organization
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO